Rice University is part of a multiuniversity research team that has secured an award of up to $34.9 million from the Advanced Research Projects Agency for Health (ARPA-H) to accelerate the development of a bioelectronic implant designed to improve adherence for obesity and type 2 diabetes (T2D) treatment while reducing development and manufacturing costs.
Resilience allocates $225M to expand manufacturing capacity in Cincinnati
National Resilience is working to expand its clinical and commercial drug manufacturing capabilities to provide more than 200 million units to its clients by 2025.